EMD Serono, Canada, is an affiliate of Merck KGaA, Darmstadt, Germany. With a rich history, we have always been committed the needs of Canadians. As an organization, EMD Serono, Canada is known for its innovative products and services that support patients in the area of neurodegenerative diseases, fertility, and endocrinology.
Our team of over 100 employees across the country are dedicated to improve the lives of Canadians who are challenged by their disease. Our employees work across many disciplines such as, medical affairs, regulatory affairs, drug safety and medical information, quality assurance, sales and marketing, patient access, compliance, and patient support. To support our R&D efforts, we have established a biotech product development site that is devoted to the development of an innovative cancer vaccine currently in multinational phase III clinical trials.
EMD Serono – A Global Context
Merck KGaA of Darmstadt, Germany, is a leading company for innovative and top-quality high-tech products in the pharmaceutical and chemical sectors. Our subsidiaries in Canada and the United States operate under the umbrella brand EMD. Around 38,000 employees work in 66 countries to improve the quality of life for patients, to further the success of our customers and to help meet global challenges.
Merck KGaA of Darmstadt, Germany, is the world's oldest pharmaceutical and chemical company. Since 1668 our name has stood for innovation, business success and responsible entrepreneurship. The founding family remains the majority owner of the company to this day.